Jill O'Donnell-Tormey - May 18, 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Jill O'Donnell-Tormey
Stock symbol
CHRS
Transactions as of
May 18, 2022
Transactions value $
$0
Form type
4
Date filed
5/20/2022, 04:58 PM
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +54K $0.00 54K May 18, 2022 Common Stock 54K $7.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from May 18, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.